These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 31922181)
21. Microfluidics-Assisted Surface Trifunctionalization of a Zeolitic Imidazolate Framework Nanocarrier for Targeted and Controllable Multitherapies of Tumors. Shen J; Ma M; Zhang H; Yu H; Xue F; Hao N; Chen H ACS Appl Mater Interfaces; 2020 Oct; 12(41):45838-45849. PubMed ID: 32956582 [TBL] [Abstract][Full Text] [Related]
22. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer. Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060 [TBL] [Abstract][Full Text] [Related]
23. Near-Infrared Light-Triggered Drug Release from Ultraviolet- and Redox-Responsive Polymersome Encapsulated with Core-Shell Upconversion Nanoparticles for Cancer Therapy. Tsai MF; Lo YL; Soorni Y; Su CH; Sivasoorian SS; Yang JY; Wang LF ACS Appl Bio Mater; 2021 Apr; 4(4):3264-3275. PubMed ID: 35014413 [TBL] [Abstract][Full Text] [Related]
24. A reversible, switchable pH-driven quaternary ammonium pillar[5]arene nanogate for mesoporous silica nanoparticles. Santos ECS; Dos Santos TC; Fernandes TS; Jorge FL; Nascimento V; Madriaga VGC; Cordeiro PS; Checca NR; Da Costa NM; Pinto LFR; Ronconi CM J Mater Chem B; 2020 Jan; 8(4):703-714. PubMed ID: 31867589 [TBL] [Abstract][Full Text] [Related]
25. CRISPR-dCas9-Guided and Telomerase-Responsive Nanosystem for Precise Anti-Cancer Drug Delivery. Ma Y; Mao G; Wu G; Cui Z; Zhang XE; Huang W ACS Appl Mater Interfaces; 2021 Feb; 13(7):7890-7896. PubMed ID: 33513005 [TBL] [Abstract][Full Text] [Related]
26. Polymeric nanoparticles responsive to intracellular ROS for anticancer drug delivery. Xu L; Zhao M; Gao W; Yang Y; Zhang J; Pu Y; He B Colloids Surf B Biointerfaces; 2019 Sep; 181():252-260. PubMed ID: 31153020 [TBL] [Abstract][Full Text] [Related]
27. Bilayer Nanocarriers with Protein-Acid Conjugation for Prolonged Release and Enhanced Anticancer Effects. Hou H; Zhang D; Zeng J; Zhou L; Wang Z; Yao M; Ren J; Hu N; Wang Y Langmuir; 2019 Mar; 35(10):3710-3716. PubMed ID: 30727729 [TBL] [Abstract][Full Text] [Related]
28. pH-labile and photochemically cross-linkable polymer vesicles from coumarin based random copolymer for cancer therapy. Samanta P; Kapat K; Maiti S; Biswas G; Dhara S; Dhara D J Colloid Interface Sci; 2019 Nov; 555():132-144. PubMed ID: 31377639 [TBL] [Abstract][Full Text] [Related]
29. Human serum albumin-based doxorubicin prodrug nanoparticles with tumor pH-responsive aggregation-enhanced retention and reduced cardiotoxicity. Zhang B; Wan S; Peng X; Zhao M; Li S; Pu Y; He B J Mater Chem B; 2020 May; 8(17):3939-3948. PubMed ID: 32236239 [TBL] [Abstract][Full Text] [Related]
31. Bacterial cellulose hydrogel loaded with lipid nanoparticles for localized cancer treatment. Cacicedo ML; Islan GA; León IE; Álvarez VA; Chourpa I; Allard-Vannier E; García-Aranda N; Díaz-Riascos ZV; Fernández Y; Schwartz S; Abasolo I; Castro GR Colloids Surf B Biointerfaces; 2018 Oct; 170():596-608. PubMed ID: 29975908 [TBL] [Abstract][Full Text] [Related]
32. Multi-stimuli responsive mesoporous silica-coated carbon nanoparticles for chemo-photothermal therapy of tumor. Lu H; Zhao Q; Wang X; Mao Y; Chen C; Gao Y; Sun C; Wang S Colloids Surf B Biointerfaces; 2020 Jun; 190():110941. PubMed ID: 32169778 [TBL] [Abstract][Full Text] [Related]
33. Spatial, Temporal, and Dose Control of Drug Delivery using Noninvasive Magnetic Stimulation. Chen W; Cheng CA; Zink JI ACS Nano; 2019 Feb; 13(2):1292-1308. PubMed ID: 30633500 [TBL] [Abstract][Full Text] [Related]
34. Poly(amidoamine)-modified mesoporous silica nanoparticles as a mucoadhesive drug delivery system for potential bladder cancer therapy. Wang B; Zhang K; Wang J; Zhao R; Zhang Q; Kong X Colloids Surf B Biointerfaces; 2020 May; 189():110832. PubMed ID: 32070865 [TBL] [Abstract][Full Text] [Related]
35. Fabrication of doxorubicin nanoparticles by controlled antisolvent precipitation for enhanced intracellular delivery. Tam YT; To KK; Chow AH Colloids Surf B Biointerfaces; 2016 Mar; 139():249-58. PubMed ID: 26724466 [TBL] [Abstract][Full Text] [Related]
37. Cell membrane mimetic copolymer coated polydopamine nanoparticles for combined pH-sensitive drug release and near-infrared photothermal therapeutic. Wang L; Dai W; Yang M; Wei X; Ma K; Song B; Jia P; Gong Y; Yang J; Zhao J Colloids Surf B Biointerfaces; 2019 Apr; 176():1-8. PubMed ID: 30590344 [TBL] [Abstract][Full Text] [Related]
38. Multi-functional core-shell Fe S R; M P Colloids Surf B Biointerfaces; 2019 Feb; 174():252-259. PubMed ID: 30469046 [TBL] [Abstract][Full Text] [Related]
39. Development of l-Tyrosine-Based Enzyme-Responsive Amphiphilic Poly(ester-urethane) Nanocarriers for Multiple Drug Delivery to Cancer Cells. Aluri R; Jayakannan M Biomacromolecules; 2017 Jan; 18(1):189-200. PubMed ID: 28064504 [TBL] [Abstract][Full Text] [Related]
40. Stepwise dual pH and redox-responsive cross-linked polypeptide nanoparticles for enhanced cellular uptake and effective cancer therapy. Qu J; Wang R; Peng S; Shi M; Yang ST; Luo JB; Lin J; Zhou QH J Mater Chem B; 2019 Dec; 7(45):7129-7140. PubMed ID: 31663585 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]